NEW YORK (GenomeWeb News) – GeneGo said today that GlaxoSmithKline has extended a licensing agreement for its systems biology software tools.
The expanded agreement provides GSK’s researchers in bioinformatics, R&D, and clinical studies with global access to GeneGo’s MetaCore, MapEditor, and MetaBase informatics tools.
GSK will use MetaCore, a collection of pathway maps and network models, as “a repository of all types of experimental data as well as resulting analyses,” GeneGo said.
GSK has been a GeneGo customer since 2005, when it signed an agreement to use the company’s MetaBase database of human biology and medicinal chemistry.
Financial terms of the expanded agreement were not provided.